Caroline Nilsson
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy (NCT02402231) | Caroline Nilsson | 2013-10-01 |
Track Caroline Nilsson automatically
Every clearance here is in the API, with alerts when new ones post.